Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 2235-2239

  Uno, Takashi ^a,b   Ito, Hisao ^a   Itami, Jun ^b   Yasuda, Shigeo ^a   Isobe, Koichi ^a   Hara, Ryusuku ^a   Sato, Takashi ^b   Minoura, Shigeki ^b   Shigematsu, Naoyuki ^c   Kubo, Atsushi ^c  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Carcinoma; Pelvic lymph node metastasis; Radiation therapy; Radical hysterectomy; Uterine cervix

Indexed keywords

CESIUM 137; COBALT 60;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RADIOISOTOPE THERAPY; TREATMENT FAILURE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; INTESTINAL DISEASES; LYMPHATIC METASTASIS; LYMPHEDEMA; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC NEOPLASMS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0033884261     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Benedet J, Odicino F, Maisonneuve P, Severi G, Creasman W, Shepherd J and Sideri M: Carcinoma of the cervix uteri. J Epidemiol Biostat 3: 5-34, 1998.
2. Burghardt E, Baltzer J, Harjanto TA and Haas J: Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 70: 648-655, 1992.
3. Averette HE, Nguyen HN, Donato D, Penalver MA, Sevin BU, Estape R and Little WA: Radical hysterectomy for invasive cervical cancer: a 25-year prospective experience with the Miami technique. Cancer 71: 1422-1437, 1993.
4. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT and Major F: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study, Gynecol Oncol 38: 352-357, 1990.
5. Sevin BU, Lu Y, Bloch DA, Nadji M, Koechli OR and Averette HE: Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 78: 1438-1446, 1996.
6. Fuller AF, Elliott N, Kosloff C, Hoskins WJ and Lewis Jr JL: Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 33: 34-39, 1989.
7. Samlal RAK, van der Velden J, Ten Kate FJW, Schillthuis MS, Hart AAM and Lammes FB: Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer 80: 1234-1240, 1997.
8. Krebs HB, Helmkamp BF, Sevin BU, Poliakoff SR, Nadji M and Averrette HE: Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Obstet Gynecol 59: 422-427, 1982.
9. Ito H, Shigematsu N, Kawada T, Kubo A, Isobe K, Hara R, Yasuda S, Aruga T and Ogata H: Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy. Gynecol Oncol 67: 154-161, 1997.
10. Morrow CP: Panel Report: Is pelvic radiation beneficial in the postoperative management of stage IB squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol 10: 105-110, 1980.
11. Kinney WK, Alvarez RD, Reid GC, Schray MF, Soong SJ, Morley GW, Podratz KC and Shingleton HM: Value of adjuvant whole-pelvic irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol 34: 258-262, 1989.
12. Hart K, Han I, Deppe G, Malviva V, Malone Jr J, Christenseen C, Chuba P and Porter A: Postoperative radiation for cervical cancer with pathologic risk factors. Int J Radiat Oncol Biol Phys 37: 833-838, 1997.
13. Eifel PJ, Levenback C, Wharton JT and Oswald MJ: Time course and incidence of late complications in patients treated with radiation therapy for FIGO IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32: 1289-1300, 1995.
14. Piver MS and Chung WS: Prognostic significance of cervical lesion size and pelvic node metastasis in cervical carcinoma. Obstet Gynecol 46: 507-510, 1975.
15. Soisson AP, Soper JT, Claarke-Pearson DL, Berchuck A, Montana G and Creasman WT: Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 37: 390-395, 1990.
16. Atkovar G, Uzel O, Ozsahin M, Koca S, Sahinler I, Okkam S and Uzel R: Postoperative radiotherapy in carcinoma of the cervix: treatment results and prognostic factors. Radiother Oncol 35: 198-205, 1995.
17. Stock RG, Chen AS, Flickingeer JC, Kalnicki S and Seski J: Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys 31: 31-36, 1995.
18. Hopkins MP and Morley GW: Stage IB squamous cell cancer of the cervix: Clinicopathologic features related to survival. Am J Obstet Gynecol 164: 1520-1529, 1991.
19. van Nagell JR and Pickel H: Local spread and lymph node involvement in cervical cancer. Obstet Gynecol 52: 138-145, 1978.
20. Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB and Mortel R: Analysis of factors contributing to treatment failures in stage IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 138: 550-556, 1980.
21. Boyce JG, Fruchter RG and Nicastri AD: Prognostic factors in stage 1 carcinoma of the cervix. Cancer 53: 1175-1180, 1984.
22. Himmelmann A, Willin R, Iosif S, Jens PL, Ranstam J and Astedt B: Prospective histologic malignancy grading to indicate the degree of postoperative treatment in early cervical carcinomas. Gynecol Oncol 46: 37-41, 1992.
23. Lai CH, Hong JH, Hsueh S, Ng KK, Chang TC, Tseng CJ, Chou HH and Hung KG: Preoperative prognostic variables and the impact of postoperative adjuvant therapy on outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases. An analysis of 891 cases. Cancer 85: 1537-1546, 1999.
24. Bianchi UA, Sartori E, Pecorelli S, Cavagnini A, Baroncelli G, LaFace B and Gastaldi A: Treatment of primary invasive cervical cancer: considerations on 997 consecutive cases. Eur J Gynaccol Oncol 9: 47-53, 1988.
25. Kim RY, Salter MM and Shingleton HM: Adjuvant postoperative radiation therapy following radical hysterectomy in stage IB carcinoma of the cervix: analysis of treatment failure. Int J Radiat Oncol Biol Phys 14: 445-449, 1988.
26. Gonzalez DG, Ketting BW, van Bunningen B and van Dijk JD: Carcinoma of the uterine cervix stage IB and IIA: results of postoperative irradiation in patients with microscopic infiltration in the parametrium and/or lymph node metastasis. Int J Radiat Oncol Biol Phys 16: 389-395, 1989.
27. Frigerio L, Busci L, Rabaiotti E and Mariani A: Adjunctive radiotherapy after radical hysterectomy in high risk early stage cervical carcinoma. Assessment of morbidity and recurrence. Eur J Gynaecol Oncol 15: 132-137, 1994.
28. Lin HH, Cheng WF, Chan KWA, Chang DY, Chen CK and Huang SC: Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Obstet Gynecol 88: 274-279, 1996.
29. Garipagaoglu M, Tulunay G, Kose MF, Yalvac S, Kayikcioglu F and Cakmak A: Prognostic factors in stage IB-IIA cervical carcinomas treated with postoperative radiotherapy. Eur J Gynaecol Oncol 20: 131-135, 1999.
30. Yeh SA, Wan Leung S, Wang CJ and Chen HC: Postoperative radiotherapy in early stage carcinoma ofthe uterine cervix: treatment results and prognostic factors. Gynecol Oncol: 72: 10-15, 1999.
31. Peters WA III, Liu PY, Barrett RJ, Gordon W Jr, Stock R, Berek JF, DiSaia PJ, Souhami L, Grigshy P and Alberts DS: Cisplatin and 5-Fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase III intergroup study. Society of Gynecologic Oncologists. 1999.